B
Bull
Bull · 25%IINN
$1.48
Scenario price
$0.380
+0.008 (+2.07%)At close
Loading chart…
- High
- 0.440
- Open
- 0.440
- VWAP
- 0.40
- Vol
- 1.17M
- Mkt Cap
- 24.55M
- Low
- 0.370
- Amount
- 462.83K
- EV/EBITDA, TTM
- 0.00
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
AI analysis of Qtrex Quantum Ltd (IINN)
sellIINN is not a good buy right now for a beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock is in a weak pre-market position at 0.3967, below key resistance and near support, with bearish trend signals dominating. With no bullish proprietary signal, no recent news catalyst, neutral hedge fund and insider activity, and no financial snapshot to support a growth case, the setup does not justify an immediate purchase. Given the user's impatience and desire to act now, the direct answer is to avoid buying and wait.
Valuation Metrics
The current forward P/E ratio for Qtrex Quantum Ltd (IINN) is 3.80, compared to its 5-year average forward P/E of -1.17.
Alphio AI Price Scenarios for IINN
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
8.508-20NewsfilterQTREX Quantum Secures $10 Million in Direct Offering
- 3.508-19Newsfilter
QTREX Quantum Ltd. Advances Quantum Computing with New Technology
- 3.507-31Newsfilter
QTREX Quantum Platform Exceeds Performance Requirements Set by Strategic Partners
7.507-27GlobenewswireQTREX Launches Quantum Interconnect Research Program with Northeastern University
- 7.507-27Newsfilter
QTREX Launches Quantum Interconnect Research Program with Northeastern University
IINN FAQ — answered by Alphio AI
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.
IINN is not a good buy right now for a beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock is in a weak pre-market position at 0.3967, below key resistance and near support, with bearish trend signals dominating. With no bullish proprietary signal, no recent news catalyst, neutral hedge fund and insider activity, and no financial snapshot to support a growth case, the setup does not justify an immediate purchase. Given the user's impatience and desire to act now, the direct answer is to avoid buying and wait.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.